10th anniversary meeting BBMRI.be
On October 3rd, we celebrated the 10th anniversary of BBMRI.be in Hof Van Liere in Antwerp. Many thanks to all attendees of the meeting for making this event a [...]
B3-ISO project presented at the ICCC15 conference
On June 15th 2023, Mieke De Wilde presented at the International Conference on Culture Collections the B3-ISO project that is facilitating ISO20387 accreditation in Belgian biobanks. Have a look [...]
National Biobank Symposium Germany – implementation & experiences with the Belgian law
During the 11th National Biobank Symposium in Germany on May 26th, Manon Huizing presented the implementaton of the Belgian biobank law and first experiences. Have a look here at [...]
Activities of our Stakeholder Involvement WG presented at Knowledge for Growth meeting
During the Knowledge for Growth Meeting organized by flanders.bio on June 1st 2023, Patrick Miqueu presented the design of the public awareness campaign that is being developed within the [...]
Codex4SMEs program: collaboration between biobanks and SME’s
The Codex4SMEs program aims to support small and medium-sized (SME) companies inthe life sciences and medical technology sectors engaged in the development ofdiagnostics. BBMRI.be is included in this program [...]
High Quality Biobanking In Belgium: the Road towards ISO20387 @ Knowledge for Growth
During the Knowledge for Growth Meeting organized by flanders.bio on June 1st 2023, Mieke De Wilde presented the first results of the B3-ISO project. The poster can be found [...]
COVID19 research in Flanders
In the last weeks we have seen in Flanders numerous initiatives to respond to the COVID‐19 crisis, many of them arising bottom‐up, often in collaboration with European partnerships that received funding from the European Union’s Horizon 2020 research and innovation programme. Everywhere in the region, research groups, as well as companies, have reallocated budgets to address different issues related to the COVID‐19 pandemic. The Flemish universities and their experts play a crucial role in the guidance and decisionmaking of this unseen crisis. This is particularly challenging, as the virus is new and its pathophysiology, the epidemiology and social impact need to be better understood to develop better diagnostics, vaccines, treatments and interventions. [...]